Volume | 596,287 |
|
|||||
News | - | ||||||
Day High | 16.16 | Low High |
|||||
Day Low | 15.29 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
15.80 | 15.29 | 16.16 | 16.06 | 16.04 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,427 | 596,287 | $ 15.87 | $ 9,463,780 | - | 11.83 - 28.80 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:20:00 | formt | 1,817 | $ 16.06 | USD |
REGENXBIO Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
713.51M | 44.43M | - | 90.24M | -263.49M | -5.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
REGENXBIO News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 16.87 | 16.87 | 15.18 | 15.88 | 471,641 | -0.81 | -4.80% |
1 Month | 22.33 | 22.42 | 15.18 | 18.36 | 457,854 | -6.27 | -28.08% |
3 Months | 12.42 | 28.80 | 11.83 | 19.66 | 756,979 | 3.64 | 29.31% |
6 Months | 15.73 | 28.80 | 11.83 | 18.36 | 649,750 | 0.33 | 2.10% |
1 Year | 19.03 | 28.80 | 11.83 | 18.35 | 513,403 | -2.97 | -15.61% |
3 Years | 34.23 | 46.46 | 11.83 | 24.63 | 433,595 | -18.17 | -53.08% |
5 Years | 52.28 | 55.23 | 11.83 | 30.87 | 443,760 | -36.22 | -69.28% |
REGENXBIO Description
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |